Atea Pharmaceuticals (AVIR) Tax Provisions (2021 - 2026)
Atea Pharmaceuticals (AVIR) posted quarterly Tax Provisions of $50000.0 for Q1 2026, down 75.37% year-over-year from $203000.0 in Q1 2025, and up 100.74% quarter-over-quarter from -$6.8 million in Q4 2025.
Powered by 
Analysis
Atea Pharmaceuticals (AVIR) Tax Provisions (2021 - 2026) Analysis & Trends
Atea Pharmaceuticals' Tax Provisions history runs 6 years deep, the most recent figure standing at $50000.0 for Q1 2026.
- In Q1 2026, Tax Provisions fell 75.37% year-over-year to $50000.0; the TTM figure through Mar 2026 stood at -$6.3 million (down 804.01% YoY), while the FY2025 annual figure was -$6.2 million, down 766.16% from the prior year.
- Tax Provisions for Q1 2026 stood at $50000.0, up from -$6.8 million in the prior quarter.
- The five-year high for Tax Provisions was $349000.0 in Q4 2023, with the low at -$6.8 million in Q4 2025.
- The 5-year median for Tax Provisions is $205000.0 (2025), against an average of -$484937.5.
- The sharpest annual moves came in 2023 and 2025: Tax Provisions surged 183.74% in 2023, then plunged 3108.0% in 2025.
- Atea Pharmaceuticals' Tax Provisions stood at $123000.0 in 2022, then soared by 183.74% to $349000.0 in 2023, then slumped by 35.53% to $225000.0 in 2024, then slumped by 3108.0% to -$6.8 million in 2025, then jumped by 100.74% to $50000.0 in 2026.
- Business Quant data shows AVIR's Tax Provisions at $50000.0 in Q1 2026, -$6.8 million in Q4 2025, and $196000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.31 Bn | 131.46 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 85.65 Bn | 77.66 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn | -59.00 Mn |
| 4 | Moderna | 57.94 Bn | 52.80 Bn | 52.00 Mn | 15.00 Mn |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | - |
| 6 | BeOne Medicines | 39.96 Bn | 34.86 Bn | 1.53 Bn | 75.45 Mn |
| 7 | Alnylam Pharmaceuticals | 35.16 Bn | 31.85 Bn | 992.69 Mn | 13.31 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | - |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | 1.90 Mn |
| 10 | Atea Pharmaceuticals | 471.10 Mn | 471.10 Mn | - | 24,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 24,000.00 |
| Mar 31, 2026 | 50,000.00 |
| Dec 31, 2025 | -35.15 Mn |
| Sep 30, 2025 | 196,000.00 |
| Jun 30, 2025 | 207,000.00 |
| Mar 31, 2025 | 203,000.00 |
| Dec 31, 2024 | 225,000.00 |
| Sep 30, 2024 | 226,000.00 |
| Jun 30, 2024 | 243,000.00 |
| Mar 31, 2024 | 231,000.00 |
| Dec 31, 2023 | 349,000.00 |
| Sep 30, 2023 | 221,000.00 |
| Jun 30, 2023 | 251,000.00 |
| Mar 31, 2023 | 197,000.00 |
| Dec 31, 2022 | 123,000.00 |
| Sep 30, 2022 | -3.83 Mn |
| Jun 30, 2022 | 120,000.00 |
| Dec 31, 2021 | 4.10 Mn |
| Sep 30, 2021 | 6.10 Mn |
| Jun 30, 2021 | 7.20 Mn |